Announcements
Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with MedReviews, LLC.
Open Access
Review
Bivalirudin in Acute Coronary Syndromes and Percutaneous Coronary Intervention
Show Less
1
University of California, Los Angeles School of Medicine, Los Angeles, CA
2020
Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA
Rev. Cardiovasc. Med. 2006, 7(S3), 27–34;
Published: 20 May 2006
Abstract
The standard of care for patients with acute coronary syndrome is antithrombotic and antiplatelet therapies along with early percutaneous coronary intervention. Because of the limitations of heparin, there has been an interest in direct thrombin inhibitors, such as bivalirudin, which is now the anticoagulant of choice in percutaneous coronary intervention.
Keywords
Acute coronary syndrome
Percutaneous coronary intervention
Thrombin
Heparin
Bivalirudin